Početna › Intersticijske bolesti pluća › Florida
Kliničke studije za Intersticijske bolesti pluća u državi Florida
24 studija za Intersticijske bolesti pluća traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
- Orlando9 studija
- Tampa8 studija
- Naples5 studija
- Gainesville5 studija
- Jacksonville5 studija
- Davie4 studija
- Miami4 studija
Službeni tekst studije (engleski)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Clinical Research Specialists LLC - Kissimmee, Kissimmee
- Lakeland Regional Medical Center - Lakeland, Lakeland
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Clinical Research Specialists LLC - Kissimmee, Kissimmee
U tijeku regrutacijaFaza 3
Od 40 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA017, Gainesville
- USA006, Naples
- USA026, St. Petersburg
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- New Access Research and Medical Services, Miami
- Eunix Clinical Research, Orlando
- i još 1
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT05798923A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Kissimmee
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07816185A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Gainesville
- GSK Investigational Site, Naples
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06572384A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Jacksonville
- GSK Investigational Site, Miami
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Cleveland Clinic Florida, Weston
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- AdventHealth Orlando, Orlando
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Tampa General Hospital, Tampa
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kissimmee
U tijeku regrutacijaFaza 2
Od 18 do 85 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- NCH Research Institute, Naples
- Advent Health Medical Group Advanced Lung Disease, Orlando
- i još 3
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT06388421Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
- University of Miami Hospital and Clinics, Miami
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT07486869RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Florida, Jacksonville
U tijeku regrutacijaFaza 2/3
Od 18 do 75 godina · Oba spola · Ažurirano 17. kol 2026. · NCT06328777An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA006, Naples
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 13. kol 2026. · NCT07234032Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Florida, Gainesville
- University of South Florida, Tampa
U tijeku regrutacijaOpažajna studija
Od 21 godina i više · Oba spola · Ažurirano 12. kol 2026. · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Mayo Clinic of Florida, Jacksonville
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- University of South Florida, Tampa
U tijeku regrutacijaFaza 2
Od 4 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Ascension Medical Group St. Vincent's Lung Institute, Jacksonville
- Mayo Clinic, Jacksonville
- TGH/USF Center for Advanced Lung Disease and Lung Transplant, Tampa
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Advent Health, Orlando
- Tampa General Hospital Center of Research Excellence, Tampa
U tijeku regrutacijaOpažajna studija
Od 18 do 80 godina · Oba spola · Ažurirano 26. lip 2026. · NCT06129240Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- Mayo Clinic in Florida, Jacksonville
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 20. ožu 2026. · NCT06751069Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
- Maule Stem Cell Research Institute, Venice
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. sij 2026. · NCT07372989Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Florida Lung Asthma and Sleep Specialist, Celebration
- Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 12. stu 2025. · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Miami
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 7. svi 2025. · NCT05892614Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.